Venetoclax, Dexamethasone, Bortezomib, and Daratumumab For The Treatment Of Adolescent And Young Adults With Relapsed Or Refractory T-Cell Acute Lymphoblastic Leukemia And T-cell Acute Lymphoblastic Lymphoma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Mayo Clinic
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Fondazione Italiana Linfomi - ETS
St. Jude Children's Research Hospital
University of Ulm
University Health Network, Toronto
H. Lee Moffitt Cancer Center and Research Institute
Alliance for Clinical Trials in Oncology
St. Jude Children's Research Hospital
Gustave Roussy, Cancer Campus, Grand Paris
M.D. Anderson Cancer Center
The Lymphoma Academic Research Organisation
M.D. Anderson Cancer Center
University of Athens
UNICANCER
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Hunan Cancer Hospital
M.D. Anderson Cancer Center
Academic and Community Cancer Research United
M.D. Anderson Cancer Center
University of Maryland, Baltimore
University of Maryland, Baltimore
Lymphoma Study Association
M.D. Anderson Cancer Center
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
M.D. Anderson Cancer Center
University of Kansas Medical Center
Peking University
Alliance for Clinical Trials in Oncology
Mayo Clinic
French Innovative Leukemia Organisation
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
French Innovative Leukemia Organisation
Barbara Ann Karmanos Cancer Institute
M.D. Anderson Cancer Center
University of Miami
Hoag Memorial Hospital Presbyterian